GlassScriptPhysician profile
Spenser Cassinelli
NPI 1508208943
$11,288.49
in general payments reported to CMS, 2019-2025
27 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,311 · 2020: $1,117 · 2021: $474 · 2022: $1,765 · 2023: $617 · 2024: $728 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,622.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,107.51 | 2019 | |
| Stryker Corporation | $3,058.76 | 2019-2025 | Prostep Mica, Incompass Total Ankle System, Inbone |
| Sequoia Surgical, INC. | $665.06 | 2020 | |
| Exactech, INC. | $415.70 | 2020-2025 | |
| Smith+Nephew, INC. | $345.84 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System |
| Encore Medical, LP | $263.00 | 2021-2022 | |
| Kerecis Limited | $212.41 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Wright Medical Technology, INC. | $202.97 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $192.68 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $181.81 | 2022-2023 | |
| Alafair Biosciences, INC. | $168.65 | 2025 | Versawrap |
| Kci USA, INC. | $151.80 | 2020-2022 | |
| Avita Medical Americas, LLC | $140.38 | 2025 | Recell, Cohealyx, Permeaderm |
| Treace Medical Concepts, INC. | $137.18 | 2024 | |
| Davol INC. | $135.32 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $133.03 | 2020 | |
| Paragon 28, INC. | $126.66 | 2025 | Additive Orthopedics |
| Extremity Medical | $119.80 | 2019 | |
| Linvatec Corporation | $98.01 | 2024 | Biobrace 23mm |
| Bioventus LLC | $91.80 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Mimedx Group, INC. | $88.66 | 2025 | |
| Acell, INC. | $67.21 | 2020 | |
| Evolution Surgical, INC | $66.70 | 2023-2024 | |
| Biotissue Holdings INC. | $59.00 | 2022 | |
| Polynovo North America LLC | $23.40 | 2024 | Novosorb Btm |
| Solventum Corporation | $18.67 | 2024 | Activ.A.C. |
| Integra Lifesciences Corporation | $16.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spenser Cassinelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.